The U.S. Food and Drug Administration on April 12, 2017 permitted marketing of the Philips IntelliSite Pathology Solution (PIPS), the first whole slide imaging (WSI) system that allows for review and interpretation of digital surgical pathology slides prepared from biopsied tissue. This is the first time the FDA has permitted the marketing of a WSI system for these purposes.

Resource:

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm552742.htm